KAPOSI SARCOMA
Clinical trials for KAPOSI SARCOMA explained in plain language.
Never miss a new study
Get alerted when new KAPOSI SARCOMA trials appear
Sign up with your email to follow new studies for KAPOSI SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for rare HIV-Linked cancer
Disease control OngoingThis early-stage trial tests whether combining two anti-cancer drugs, pomalidomide and liposomal doxorubicin, can safely treat advanced or hard-to-treat Kaposi sarcoma. About 62 adults with this rare skin cancer, often linked to HIV, will receive the drugs in 4-week cycles. The m…
Matched conditions: KAPOSI SARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 07:09 UTC
-
Cancer combo trial for rare skin cancer pulled before starting
Disease control TerminatedThis study planned to test a combination of two drugs, pembrolizumab and lenvatinib, in people with classic Kaposi sarcoma that had not responded to prior chemotherapy. The goal was to see if the combination could shrink tumors better than standard chemo. However, the study was w…
Matched conditions: KAPOSI SARCOMA
Phase: PHASE2 • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New study aims to personalize kaposi sarcoma treatment in africa
Knowledge-focused OngoingThis study is observing 127 people with HIV-related Kaposi sarcoma in Malawi and South Africa to see how their cancer responds to standard chemotherapy. Researchers want to find out why some patients do better than others, based on factors like gender and virus levels. The goal i…
Matched conditions: KAPOSI SARCOMA
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 07:06 UTC
-
Hidden risk: HIV patients with rare cancers face faster bone loss
Knowledge-focused OngoingThis study looks at why people with HIV and certain cancers (like Kaposi sarcoma) may lose bone density faster. Researchers will review past CT scans from 40 adults treated at the NIH between 2005 and 2020. The goal is to find factors linked to bone loss, which can help improve f…
Matched conditions: KAPOSI SARCOMA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 26, 2026 06:58 UTC